Devices & Diagnostics
-
Devices & Diagnostics, BioPharma
FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes
Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.
-
MedCity Influencers, Devices & Diagnostics
3 Things Health Systems Must Do Today to Prepare for New Alzheimer’s Treatments
As more life-extending medications come on the market, health systems have a responsibility to make meaningful changes in how they screen and reach older adults. Earlier detection could mean millions of individuals enjoy longer lives of good cognitive health.
-
The Challenges of Temperature Controlled Logistics and How to Overcome Them
MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.
-
Devices & Diagnostics, Health Tech, Startups
Swedish Startup Snags $65M for Scanning Tech Designed to Facilitate Earlier Disease Detection
Neko Health recently raised €60 million (about $65.8 million) in Series A financing. The Stockholm-based startup’s medical scanning technology aims to conveniently and affordably collect extensive health data to aid doctors in catching diseases early. The company’s scan takes about 10 minutes and costs €250 (about $275).
-
Butterfly Network Launches AI Tool for Point-Of-Care Lung Ultrasounds
Butterfly Network recently launched an AI tool that can provide medical practitioners with an accurate B-line count from just a six-second lung ultrasound clip. By automatically counting B-lines in a lung image, the tool helps doctors quickly identify and assess a patient’s lung issues at the point of care.
-
Bausch + Lomb Broadens Eye Products Lineup Via $1.75B Deal With Novartis
Dry eye disease drug Xiidra is the centerpiece of the Bausch + Lomb acquisition. The deal with Novartis also includes two experimental products, one for eye pain and the other a medical device for delivering medicines to the eye.
-
A New Approach to Value-Based Care: Diagnostically Connecting Data and Diagnoses
The traditional transactional approach to the coding of diagnoses to support billing in a fee-for-service environment is not adequate to meet the care requirements of VBC programs.
-
MedCity Influencers, Devices & Diagnostics
Why Working with Incumbents Offers a Path to Success for Healthtech Startups
To deliver real value in today’s highly fragmented market, healthtech startups stand to significantly benefit by working with incumbents. Rather than focusing solely on disruption, these startups working with established partners concentrate on proving demonstrable ROI, clinical value, dollars saved, better outcomes and improved healthcare economics.
-
Devices & Diagnostics, Health Tech
Eyenuk’s New FDA Clearance Could Boost Adoption for Its Diabetic Retinopathy Screening Tech
Eyenuk recently received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system, which automatically detects diabetic retinopathy. The company said this FDA clearance makes its system the only AI system that is FDA-cleared for use with multiple retinal cameras produced by different manufacturers.
-
Managing the Proliferation of Data From Decentralized Trials: A Successful Path Forward
As the industry focuses on creating a more holistic, inclusive experience, these three focus areas can help bridge the gap between patient, site, and clinical research administrators and help to modernize the clinical trial experience for all.
-
Creating an Omnichannel Customer Journey in Healthcare
Improving Customer Experience and Conversion in Healthcare & Life Sciences
-
INVEST Digital Health Conference in Dallas Will Probe True Value and Not Fanciful Valuation
In an environment where capital isn’t as easy to access, INVEST Digital Health conference will seek to arm you with the right connections and meaningful insight to navigate an environment where ROI is king. Hear from payers, providers, startups, life sciences executives, VCs and more.
-
Cala Health Launches Wearable Device to Treat Hand Tremors
Cala Health recently launched its kIQ system — which it calls the first noninvasive wearable device cleared by the FDA to temporarily relieve tremors in people with essential tremor and Parkinson’s disease.
-
MedCity Influencers, Legal, Health Tech
New FDA Draft Guidance Signals Acceptance of Decentralized Trials (When Done Right)
he FDA has made a purposeful choice to write in broad strokes, stopping short of detailing ways to execute DCTs. Even so, the Agency is starting to acknowledge – and thereby support – the global shift towards expanded trial models. Essentially, the FDA is implicitly broadening the definition of clinical trials.
-
Meet the Company Building the First-Ever Noninvasive Blood Glucose Monitoring Device
Know Labs recently unveiled the prototype for its non-invasive, portable glucose monitoring device. The device incorporates the company’s proprietary body-radio frequency identification (Bio-RFID) technology — meaning its sensors deploy radio waves that travel through the skin to find and measure molecular signatures in the blood.
-
MedCity Influencers, BioPharma
Winding Back the Ageing Process Using Biological Clocks
Biological clocks could play an important role in helping to promote healthy ageing and to stem the growing incidence of age-related diseases by improving the quality of life of the aged, reducing mortality and relieving the burden on overwhelmed health and social care resources.
-
Vertos Medical Raises $26M for Minimally Invasive Spinal Procedure
Medical device maker Vertos Medical recently snagged $26 million in a Series C funding round. The company’s flagship product is a minimally invasive procedure that removes small pieces of bone and ligament that cause lumbar spinal stenosis.
Promoted
Healthcare VC Jumpstart Foundry Now Accepting Applications for Fall Funding
Early-stage healthcare innovation fund Jumpstart Foundry is accepting Fall funding applications through September 30th. Read on to find out why Jumpstart Foundry could be the missing piece in your startup’s journey to making a lasting difference in healthcare.
